Diamond Edge Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Licella is a developer of hydrothermal liquefaction technology that converts low-cost waste biomass into advanced biofuels, including sustainable aviation fuel (SAF), renewable diesel, and biomaterials.
BiotechCircular EconomyCleantechEnergyNorth Sydney, AU
Dr Len Humphreys(Executive Chairman)Professor Thomas Maschmeyer AO
TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
BiotechDeep TechLongevityMedical DevicesCambridge, GB
Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)
Co-investorsCambridge Innovation CapitalPfizer VenturesSV Health InvestorsM VenturesPfizer Venture InvestmentsStart Codon
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





